EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,582,423 | -0.9% | 8,536,208 | +4.5% | 0.00% | 0.0% |
Q2 2023 | $67,201,851 | +28.7% | 8,165,474 | +13.4% | 0.00% | +100.0% |
Q1 2023 | $52,219,677 | -14.3% | 7,202,714 | +4.8% | 0.00% | -50.0% |
Q4 2022 | $60,964,601 | -25.9% | 6,873,123 | +2.2% | 0.00% | 0.0% |
Q3 2022 | $82,318,000 | +4.9% | 6,725,340 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $78,499,000 | -40.0% | 6,635,610 | -3.5% | 0.00% | -33.3% |
Q1 2022 | $130,792,000 | -26.2% | 6,876,539 | +3.0% | 0.00% | -25.0% |
Q4 2021 | $177,192,000 | -33.1% | 6,673,897 | +3.6% | 0.00% | -42.9% |
Q3 2021 | $264,685,000 | -27.9% | 6,443,150 | -0.6% | 0.01% | -22.2% |
Q2 2021 | $367,250,000 | +37.8% | 6,483,932 | +2.1% | 0.01% | +28.6% |
Q1 2021 | $266,606,000 | -34.7% | 6,347,754 | +9.0% | 0.01% | -41.7% |
Q4 2020 | $408,383,000 | +155.0% | 5,824,886 | +2.0% | 0.01% | +140.0% |
Q3 2020 | $160,168,000 | -6.0% | 5,708,036 | -0.9% | 0.01% | -16.7% |
Q2 2020 | $170,395,000 | +82.4% | 5,760,473 | +22.3% | 0.01% | +50.0% |
Q1 2020 | $93,439,000 | -30.9% | 4,712,033 | +3.2% | 0.00% | -20.0% |
Q4 2019 | $135,247,000 | +37.7% | 4,567,616 | +5.8% | 0.01% | +25.0% |
Q3 2019 | $98,209,000 | -7.5% | 4,318,765 | +0.7% | 0.00% | 0.0% |
Q2 2019 | $106,156,000 | +10.3% | 4,290,861 | +9.0% | 0.00% | 0.0% |
Q1 2019 | $96,225,000 | +9.5% | 3,935,605 | +1.9% | 0.00% | 0.0% |
Q4 2018 | $87,860,000 | -26.0% | 3,862,012 | +3.6% | 0.00% | -20.0% |
Q3 2018 | $118,675,000 | -7.7% | 3,729,579 | +3.9% | 0.01% | 0.0% |
Q2 2018 | $128,557,000 | +28.6% | 3,587,970 | +19.0% | 0.01% | +25.0% |
Q1 2018 | $99,984,000 | +17.5% | 3,016,108 | +8.9% | 0.00% | 0.0% |
Q4 2017 | $85,074,000 | +54.3% | 2,768,403 | +20.5% | 0.00% | +33.3% |
Q3 2017 | $55,146,000 | +50.9% | 2,296,755 | +5.5% | 0.00% | +50.0% |
Q2 2017 | $36,533,000 | -15.4% | 2,177,146 | +12.5% | 0.00% | 0.0% |
Q1 2017 | $43,193,000 | +102.2% | 1,935,173 | +47.0% | 0.00% | +100.0% |
Q4 2016 | $21,365,000 | +26.8% | 1,316,384 | +5.3% | 0.00% | 0.0% |
Q3 2016 | $16,844,000 | +29.5% | 1,249,559 | +134.5% | 0.00% | 0.0% |
Q2 2016 | $13,004,000 | -49.8% | 532,969 | -29.0% | 0.00% | -50.0% |
Q1 2016 | $25,915,000 | – | 750,292 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |